According to the latest disclosures from the Hong Kong Stock Exchange, FMR LLC increased its holdings in GENSCRIPT BIO (01548) by 6.846 million shares on September 24.

The shares were purchased at HK$40.2549 each, for a total consideration of approximately HK$276 million.

Following the increase, FMR LLC's latest holding stands at approximately 120 million shares, representing a 5.26% stake.